Are you a basic or translational pain researcher? Then sign up for #EFIC2023 right away!
The next EFIC Congress taking place in Budapest, Hungary on 20-22 September 2023 is a great opportunity for researchers as it provides them with a large international network of health professionals from all over the world. During dedicated face-to-face networking sessions, researchers will have the opportunity to discuss ideas and findings from their basic/translational work with clinicians with expertise in different areas of pain.
Use this opportunity to move knowledge from the bench to the bedside for the benefit of patients. Register for #EFIC2023 now and find out how basic and clinical researchers present their findings together and network with each other!
Discover the basic science sessions at #EFIC2023:
| HOW PERCEPTION SHAPES BEHAVIOUR: FROM THEORETICAL TO EXPERIMENTAL TO CLINICAL | The differential diagnosis of widespread generalized fears using computational modelling Speaker: Jonas Zaman (Belgium)
Poor Proprioceptive Accuracy is Associated With Overprotective Pain-related Avoidance Behavior Perceptual bias in clinical pain and the impact on fear and behaviour |
| STATE-OF-THE-ART APPROACHES FOR TRANSLATIONAL PRECLINCAL PAIN RESEARCH: PRESENT AND FUTURE | Technological advances in pain-related behavioral assessment in rodents Speaker: Daniel Segelcke (Germany)
Confounding factors on preclinical pain studies in rodents Learning from pain studies in rodents: severity assessment in biomedical research |
| PERIPHERAL AND CENTRAL GLIAL CELLS IN SENSORY FUNCTIONS: SPOTLIGHT ON PAIN AND ITCH |
Role of glia in chronic pain Neuroimmune regulation of pain: Targeting glial cells and their interactions with sensory neurons Role of glial cells in itch Plasticity of satellite glial cells and their role in physiologic and pathological conditions |
| CELL-TYPE-SPECIFIC CONTROL OF PAIN MODULATION IN AMYGDALA-CORTICAL CIRCUITS |
Microglial activation in the central amygdala impairs analgesia during neuropathic pain Antagonistic microcircuitry in the central amygdala underlies bidirectional pain modulation Anterior cingulate mechanisms of socially transferred pain and negative affect Cingulate opioidergic ensembles constrain nociception to limit pain aversion |
| MECHANISTIC HIGHLIGHTS AT THE NEURO-IMMUNE INTERFACE OF NOCICEPTION: FROM MOUSE TO MAN | Neuron-macrophage crosstalk: from active pain resolution to control of persistent osteoarthritis pain Speaker: Niels Eijkelkamp (Netherlands)
Meningeal immune cells: novel players in neuropathic pain Pro-nociceptive neutrophils: an immunological basis for chronic widespread pain |
Discover the translational sessions at #EFIC2023:
| BRAIN-GUT-BRAIN NEUROIMMUNE SIGNALING IN VISCERAL PAIN | Visceral nociception in colitis Speaker: David Bulmer (United Kingdom)
Intestinal dysbiosis and visceral hypersensitivity Sex, Pain and the Microbiome |
| NOVEL DATA-DRIVEN BIOPSYCHOSOCIAL APPROACHES FOR PERSONALIZED DIAGNOSTICS AND PROGNOSTICS OF CHRONIC PAIN | Classifying chronic pain using multidimensional pain-agnostic symptom assessments and clustering analysis Speaker: Gadi Gilam (Israel)
A data-driven biopsychosocial framework for determining the spreading of chronic pain Experimental and psychological pain profiles in healthy and chronic pain conditions: A lifespan approach |
| ADVANCES IN SERUM BIOMARKERS IN CHRONIC PAIN: OMICS AND BEYOND | Human skin proteomics in acute pain Speaker: Manuela Schmidt (Austria)
Proteomics in fibromyalgia and chronic peripheral neuropathic pain Biomarkers in CRPS |
| THE ENDOCANNABINOID SYSTEM AND PAIN: A TRANSLATIONAL FRAMEWORK |
The endocannabinoid system in pain-negative affect interactions: preclinical and clinical evidence Cognitive impairment in chronic pain – role of endocannabinoids Behavioural and neural correlates of endocannabinoids in the human pain experience |
| CARDIOVASCULAR DISEASE AND PAIN: STUDY OF COMMON MECHANISMS | Mapping the relationship between cardiovascular disease and pain sensitivity Speaker: Christopher Nielsen (Norway)
Dissecting the underlying biological pathways of osteoarthritis pain and cardiovascular disease using genetics A mouse model for the study of pain, affective disorders and cardiovascular comorbidity |
| NEUROPATHIC PAIN DEBATE | Personalized treatment in neuropathic pain: What pinpoints responder? Speaker: Didier Bouhassira (France) Speaker: Claudia Sommer (Germany) |
| INDIVIDUALISING COMPLEX REGIONAL PAIN SYNDROME: CLASSIFICATION & REHABILITATION | Classification: Current taxonomy and proposed subgroups Speaker: Florian Brunner (Switzerland)
A new biomarker differentiates CRPS from other Chronic Limb Pain (CLP): insights into mechanism-based therapeutic interventions tailored to the individual Rehabilitation: Individualised multisensory rehabilitation model for CRPS |
| TO INHIBIT, OR TO FACILITATE? TRANSLATING MECHANISMS UNDERLYING THE TRANSITION FROM ACUTE TO CHRONIC PAIN IN ANIMAL AND HUMAN RESEARCH | Nociception and pain: The translatability of spinal facilitatory and brain inhibitory paradigms and their objective measurement Speaker: Kirsty Bannister (United Kingdom)
The effects of cognitive factors and transcranial brain stimulation on descending inhibitory control in experimental and chronic pain conditions Cognition and learning may diminish or increase upstream pro-nociceptive mechanisms such as secondary hyperalgesia |
| MANAGING WORK-RELATED MUSKULOSKELETAL DISORDERS – BIOPSYCHOSOCIAL MODEL VS ERGONOMICS | Work-related musculoskeletal pain, ergonomics and EU guidelines Speaker: Sarah Copsey (Spain)
Is there a causal relationship between lifting and LBP? Diagnostic labelling as a gateway to quicker return-to-work |
| TRANSLATIONAL RESEARCH TO IDENTIFY NOVEL MECHANISMS, BIOMARKERS AND TREATMENTS FOR PAIN: PROMISING OR UNCERTAIN PROSPECTS? | Introduction to the concept of translational pain research with examples in musculoskeletal pain Speaker: Thomas Graven-Nielsen (Denmark)
Translational pain research: new approaches in mice and men to enhance personalized pain management The (uncertain) prospect of improving analgesic drug development and optimizing pain treatments using human biomarkers of nociception Understanding chronic pain: opportunities and challenges of the translation from human experimental to clinical research and back |
| TAILORING EXERCISE FOR INDIVIDUALS WITH CHRONIC MUSCULOSKELETAL PAIN: OPPORTUNITIES AND BARRIERS |
One size does not fit all in managing spinal related pain The influence of attentional strategies on pain during exercise Tailoring exercise programmes for people with musculoskeletal pain based on physical and psychological features |
| PATIENT PARTNERSHIPS AND CO-PRODUCING HEALTHCARE: RESEARCHER, CLINICAL ACADEMIC AND PATIENT PERSPECTIVES AND EXPERIENCES | Introduction to patient partnerships and a clinical academic’s perspective and experience of patient partnerships informing research in sickle cell related pain Speaker: Rebecca McLoughlin (United Kingdom)
Researcher perspectives and experiences of partnerships informing research in spinal pain Co-producing healthcare: Perspectives from a person living with persistent pain |
| SEX- AND GENDER-SPECIFIC ASPECTS IN ANIMAL AND HUMAN EXPERIMENTAL MIGRAINE MODELS | Sex differences in responses to a CGRP-targeting antibody in experiments of rodent meningeal nociception Speaker: Karl Messlinger (Germany)
Sex differences in preclinical models of migraine and their implication for the clinical phenotype Sex- and gender-specific aspects of responses to TRP channel ligands and CGRP in humans |
| PSYCHOLOGICAL ASPECTS | Cognitive behavioural approaches for chronic pain – who benefits and how to do better? Speaker: Lance McCracken (Sweden) |
| UN-WORKSHOPPING: BRIDGING A GAP WITH PAIN ASSESSMENT |
Un-workshopping: Bridging a gap with pain assessment Speaker: Kristian Kjær-Staal Petersen (Denmark) Un-workshopping: Bridging a gap with pain assessment Un-workshopping: Bridging a gap with pain assessment |
| MIGRAINE: PATHOMECHANISM, NOVEL THERAPEUTIC POSSIBILITIES AND RECENT DRUG DEVELOPMENT OR NOVEL INSIGHTS IN THE PATHOPHYSIOLOGICAL MECHANISMS OF MIGRAINE |
CGRP in migraine: history and recent findings CGRP-based treatment strategies: clinical evidences PACAP and kynurenines in migraine: preclinical data, therapeutic considerations |
